Website
www.kisojibiotech.com
Email
gordon.ngan@kbimail.com
LinkedIn
Visit our page
Line of business
Therapeutics - Oncology
KisoJi is a privately-held next-generation antibody company developing multi-specific antibodies to improve outcomes in oncology.